Exit Notice

You are about to leave ClinicalTrials.gov and go to: To obtain contact information for a study center near you, click here. URL: https://trialinfoemail.pfizer.com/pages/landing.aspx?StudyID=3066K1-404&StudyName=Temsirolimus%20Versus%20Sorafenib%20As%20Second-Line%20Therapy%20In%20Patients%20With%20Advanced%20RCC%20%20Who%20Have%20Failed%20First-Line%20Sunitinib

Click on the link to continue or return to ClinicalTrials.gov Home